Complete financial analysis of Mountain Valley MD Holdings Inc. (MVMD.CN) income statement, including revenue, profit margins, EPS and key performance metrics. Get detailed insights into the financial performance of Mountain Valley MD Holdings Inc., a leading company in the Drug Manufacturers – Specialty & Generic industry within the Healthcare sector.
- MoneyHero Limited Warrants (MNYWW) Income Statement Analysis – Financial Results
- Chiyoda Integre Co.,Ltd. (6915.T) Income Statement Analysis – Financial Results
- Guangdong Ganhua Science and Industry Co., Ltd. (000576.SZ) Income Statement Analysis – Financial Results
- Veji Holdings Ltd. (VEJIF) Income Statement Analysis – Financial Results
- N.B.I. Industrial Finance Company Limited (NBIFIN.NS) Income Statement Analysis – Financial Results
Mountain Valley MD Holdings Inc. (MVMD.CN)
Industry: Drug Manufacturers - Specialty & Generic
Sector: Healthcare
Website: https://www.mountainvalleymd.com
About Mountain Valley MD Holdings Inc.
Mountain Valley MD Holdings Inc., through its subsidiary, Mountain Valley MD Inc., operates as a health and wellness company. The company engages in the implementation and licensing of its technologies to pharmaceutical, vaccine, and nutraceutical third parties. It offers Quicksome oral drug formulation and delivery technologies; Quicksol solubility formulation technology; and dose sparing adjuvant. In addition, the company is developing IM032 for the treatment of male beagle dogs for comparing intramuscular and subcutaneous dosing. Mountain Valley MD Holdings Inc. is headquartered in Concord, Canada.
| Metric | 2023 | 2022 | 2021 | 2020 | 2019 | 2018 | 2017 | 2016 | 2015 |
|---|---|---|---|---|---|---|---|---|---|
| Revenue | 60.00K | 0.00 | 110.00K | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 |
| Cost of Revenue | 406.00K | 446.00K | 40.00K | 430.19K | 52.16K | 0.00 | 39.70K | 48.02K | 48.00K |
| Gross Profit | -346.00K | -446.00K | 70.00K | -430.19K | -52.16K | 0.00 | -39.70K | -48.02K | -48.00K |
| Gross Profit Ratio | -576.67% | 0.00% | 63.64% | 0.00% | 0.00% | 0.00% | 0.00% | 0.00% | 0.00% |
| Research & Development | 70.00K | 1.47M | 2.21M | 1.18M | 52.16K | 0.00 | 0.00 | 0.00 | 0.00 |
| General & Administrative | 2.57M | 3.63M | 7.15M | 3.55M | 2.45M | 1.79M | 0.00 | 0.00 | 0.00 |
| Selling & Marketing | 200.00K | 0.00 | 0.00 | 0.00 | 570.83K | 317.47K | 0.00 | 0.00 | 0.00 |
| SG&A | 2.77M | 3.63M | 7.15M | 3.55M | 3.02M | 887.23K | 923.00K | 747.57K | 1.39M |
| Other Expenses | 0.00 | 446.00K | 451.00K | 0.00 | 75.86K | 0.00 | 0.00 | 0.00 | 0.00 |
| Operating Expenses | 60.00K | 5.55M | 9.81M | 5.16M | 3.10M | 887.23K | 923.00K | 747.57K | 1.39M |
| Cost & Expenses | 3.25M | 5.55M | 9.85M | 5.16M | 3.15M | 887.23K | 962.70K | 795.59K | 1.43M |
| Interest Income | 274.00K | 267.00K | 5.00K | 5.00K | 2.03K | 23.52K | 889.00 | 227.00 | 1.80K |
| Interest Expense | 0.00 | 3.83M | 5.00K | 20.18K | 37.24K | 9.80K | 0.00 | 0.00 | 0.00 |
| Depreciation & Amortization | 416.00K | 446.00K | 451.00K | 430.19K | 75.86K | 2.13M | 39.70K | 48.02K | 48.00K |
| EBITDA | -3.19M | -6.89M | -9.29M | -7.57M | -18.51M | 0.00 | -922.12K | -747.34K | -1.38M |
| EBITDA Ratio | -5,321.67% | 0.00% | -8,136.36% | 0.00% | 0.00% | 0.00% | 0.00% | 0.00% | 0.00% |
| Operating Income | -3.19M | -3.50M | -9.74M | -5.28M | -3.23M | -887.23K | -962.70K | -795.59K | -1.43M |
| Operating Income Ratio | -5,310.00% | 0.00% | -8,856.36% | 0.00% | 0.00% | 0.00% | 0.00% | 0.00% | 0.00% |
| Total Other Income/Expenses | -4.58M | -2.23M | 33.00K | -2.86M | -15.62M | -9.80K | 889.00 | 227.00 | 1.80K |
| Income Before Tax | -7.76M | -7.33M | -9.71M | -8.14M | -18.84M | -897.03K | -961.82K | -795.36K | -1.43M |
| Income Before Tax Ratio | -12,936.67% | 0.00% | -8,826.36% | 0.00% | 0.00% | 0.00% | 0.00% | 0.00% | 0.00% |
| Income Tax Expense | -92.00K | 109.00K | 336.00K | -104.82K | -46.09K | -47.04K | 0.00 | 3.00 | 4.00 |
| Net Income | -7.67M | -7.44M | -9.71M | -8.14M | -18.80M | -897.03K | -961.82K | -795.36K | -1.43M |
| Net Income Ratio | -12,783.33% | 0.00% | -8,826.36% | 0.00% | 0.00% | 0.00% | 0.00% | 0.00% | 0.00% |
| EPS | -0.02 | -0.02 | -0.03 | -0.03 | -0.09 | -0.08 | -0.23 | -0.29 | -0.63 |
| EPS Diluted | -0.02 | -0.02 | -0.03 | -0.03 | -0.09 | -0.08 | -0.23 | -0.29 | -0.63 |
| Weighted Avg Shares Out | 329.65M | 329.65M | 329.24M | 263.51M | 208.41M | 11.72M | 4.20M | 2.78M | 2.28M |
| Weighted Avg Shares Out (Dil) | 329.65M | 329.65M | 329.24M | 263.51M | 208.41M | 11.72M | 4.20M | 2.78M | 2.28M |
Source: https://incomestatements.info
Category: Stock Reports